Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial

BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a nuclear receptor that modulates inflammation in models of asthma. To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, J. R., Mortimer, K., Pang, L., Smith, K. M, Bailey, H., Hodgson, D. B., Shaw, D. E., Knox, A. J., Harrison, T. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999189/
https://www.ncbi.nlm.nih.gov/pubmed/27560168
http://dx.doi.org/10.1371/journal.pone.0160257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999189/
https://www.ncbi.nlm.nih.gov/pubmed/27560168
http://dx.doi.org/10.1371/journal.pone.0160257

Ejemplares similares